Outcomes of Inhaled Amikacin and Clofazimine-Containing Regimens for Treatment of Refractory Mycobacterium avium Complex Pulmonary Disease

Limited data are available regarding optimal treatment for refractory Mycobacterium avium complex-pulmonary disease (MAC-PD). We evaluated outcomes of inhaled amikacin (AMK) with clofazimine (CFZ) regimens as an add-on salvage therapy for refractory MAC-PD. We retrospectively analyzed 52 patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Bo-Guen, Kim, Hojoong, Kwon, O. Jung, Huh, Hee Jae, Lee, Nam Yong, Baek, Sun-Young, Sohn, Insuk, Jhun, Byung Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565500/
https://www.ncbi.nlm.nih.gov/pubmed/32937940
http://dx.doi.org/10.3390/jcm9092968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565500/
https://www.ncbi.nlm.nih.gov/pubmed/32937940
http://dx.doi.org/10.3390/jcm9092968

Ejemplares similares